Absci Corporation (ABSI)
NASDAQ: ABSI · IEX Real-Time Price · USD
4.770
-0.200 (-4.02%)
At close: Apr 19, 2024, 4:00 PM
4.780
+0.010 (0.21%)
After-hours: Apr 19, 2024, 7:38 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $537.98 million as of April 19, 2024. Its market cap has increased by 211.69% in one year.
Market Cap
537.98M
Enterprise Value
440.09M
1-Year Change
211.69%
Ranking
Category
Stock Price
$4.77
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has decreased from $1.45B to $537.98M, a decrease of -62.79%. That is a compound annual growth rate of -30.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 538.00M | -4.01% |
Apr 18, 2024 | 560.50M | -6.05% |
Apr 17, 2024 | 596.60M | -1.68% |
Apr 16, 2024 | 606.80M | -0.91% |
Apr 15, 2024 | 612.40M | -6.86% |
Apr 12, 2024 | 657.50M | -4.20% |
Apr 11, 2024 | 686.30M | 0.09% |
Apr 10, 2024 | 685.70M | -7.67% |
Apr 9, 2024 | 742.70M | 16.76% |
Apr 8, 2024 | 636.10M | -1.75% |
Apr 5, 2024 | 647.40M | 2.68% |
Apr 4, 2024 | 630.50M | 5.28% |
Apr 3, 2024 | 598.90M | 3.31% |
Apr 2, 2024 | 579.70M | -8.38% |
Apr 1, 2024 | 632.70M | -1.23% |
Mar 28, 2024 | 640.60M | 2.53% |
Mar 27, 2024 | 624.80M | 6.33% |
Mar 26, 2024 | 587.60M | 2.96% |
Mar 25, 2024 | 570.70M | 2.22% |
Mar 22, 2024 | 558.30M | -6.25% |
Mar 21, 2024 | 595.50M | 25.87% |
Mar 20, 2024 | 473.10M | 5.84% |
Mar 19, 2024 | 447.00M | 3.21% |
Mar 18, 2024 | 433.10M | -4.90% |
Mar 15, 2024 | 455.40M | 2.29% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nuvation Bio | 612.71M |
Lyell Immunopharma | 612.37M |
Mobile-health Network Solutions | 612.00M |
Canopy Growth | 610.47M |
Astria Therapeutics | 609.42M |
Quanterix | 606.73M |
Olema Pharmaceuticals | 605.00M |
The Pennant Group | 600.55M |